Swiss pharmaceutical company Roche offers to buy the roughly 44% of U.S. biotech firm Genentech it doesn't already own for nearly $44 billion. WSJ's Jacob Goldstein says this is no ordinary offer and ...
4 months ago
The Wall Street Journal
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
...Swiss drugmaker's offer to buy the rest of Genentech Inc. for $43.7 billion to gain the largest U.S. maker of cancer medicines. Investors in South San Francisco, California-based Genentech would ...
4 months ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to: